{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T08:52:17Z","timestamp":1771577537547,"version":"3.50.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Recent studies have demonstrated epigenetic regulation of immune responses. Nevertheless, the underlying effect of RNA N6-methyladenosine (m6A) modifications on tumor microenvironment cell infiltration remains elusive. In this study, we thoroughly assessed m6A modification patterns of 255 myeloid leukemia specimens based on 23 m6A regulators. Consensus clustering of the 23 m6A regulators was performed to determine three distinct m6A modification patterns that were remarkably consistent with three immunophenotypes of tumors: immunorejection, immune activation, and immune inertness. Further evaluation and prognostic analysis of the m6A modification patterns of individual tumors revealed that low m6A score was characterized by increased mutational burden, immune activation, and survival rates, whereas high m6A score was characterized by poorer survival rates and the absence of effective immune infiltration. In addition, this study investigated the association between m6A regulators and antitumor immune responses and discovered higher expression of the immune regulators <jats:italic>PD-L1<\/jats:italic>, <jats:italic>PD-L2<\/jats:italic>, <jats:italic>MRP1<\/jats:italic>, and <jats:italic>MRP2<\/jats:italic> in low m6A scores. Generally, the expression pattern of m6A regulators was remarkably associated with prognostic results and antitumor immune responses in acute myeloid leukemia and may be an underlying target and biological marker for immune therapies.<\/jats:p>","DOI":"10.3389\/fimmu.2021.789914","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T13:16:30Z","timestamp":1638278190000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Acute Myeloid Leukemia"],"prefix":"10.3389","volume":"12","author":[{"given":"Ashuai","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunmei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baili","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianlong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiangqiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00277-020-03938-2","article-title":"Updates on DNA Methylation Modifiers in Acute Myeloid Leukemia","volume":"99","author":"Contieri","year":"2020","journal-title":"Ann Hematol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-018-0286-2","article-title":"Post-Remission Strategies for the Prevention of Relapse Following Allogeneic Hematopoietic Cell Transplantation for High-Risk Acute Myeloid Leukemia: Expert Review From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"54","author":"Lee","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2016.67.5892","article-title":"Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common But Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008","volume":"34","author":"Ganzel","year":"2016","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/hon.915","article-title":"Remission Induction, Consolidation and Novel Agents in Development for Adults With Acute Myeloid Leukaemia","volume":"28","author":"Hamadani","year":"2010","journal-title":"Hematol Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1053\/j.seminhematol.2018.08.005","article-title":"What\u2019s New in Consolidation Therapy in AML","volume":"56","author":"Schlenk","year":"2019","journal-title":"Semin Hematol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.3390\/cancers12123744","article-title":"Modulating the Crosstalk Between the Tumor and the Microenvironment Using SiRNA: A Flexible Strategy for Breast Cancer Treatment","volume":"12","author":"Roscigno","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ceb.2017.05.006","article-title":"Metabolism Shapes the Tumor Microenvironment","volume":"48","author":"Reina-Campos","year":"2017","journal-title":"Curr Opin Cell Biol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.semcancer.2019.12.018","article-title":"The Balance Between Breast Cancer and the Immune System: Challenges for Prognosis and Clinical Benefit From Immunotherapies","volume":"72","author":"Baxevanis","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2020.05.009","article-title":"Engineering Chimeric Antigen Receptor T Cells Against Immune Checkpoint Inhibitors PD-1\/PD-L1 for Treating Pancreatic Cancer","volume":"17","author":"Yang","year":"2020","journal-title":"Mol Ther Oncolytics"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 Attenuates Tumour Response to PD-L1 Blockade by Contributing to Exclusion of T Cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.Cir-18-0436","article-title":"Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures","volume":"7","author":"Zeng","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2016.01.043","article-title":"Tumor Microenvironment and Therapeutic Response","volume":"387","author":"Wu","year":"2017","journal-title":"Cancer Lett"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0096-5","article-title":"Phenotype Molding of Stromal Cells in the Lung Tumor Microenvironment","volume":"24","author":"Lambrechts","year":"2018","journal-title":"Nat Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00784","article-title":"The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies","volume":"11","author":"Petitprez","year":"2020","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","article-title":"Macrophages and Metabolism in the Tumor Microenvironment","volume":"30","author":"Vitale","year":"2019","journal-title":"Cell Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2020.05.034","article-title":"Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy","volume":"78","author":"Bader","year":"2020","journal-title":"Mol Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrm.2016.132","article-title":"Post-Transcriptional Gene Regulation by mRNA Modifications","volume":"18","author":"Zhao","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay6018","article-title":"N (6)-Methyladenosine of Chromosome-Associated Regulatory RNA Regulates Chromatin State and Transcription","volume":"367","author":"Liu","year":"2020","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N(6)-Methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat Cell Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23942","article-title":"Effects of m6A RNA Methylation Regulators on Endometrial Cancer","volume":"35","author":"Zhang","year":"2021","journal-title":"J Clin Lab Anal"},{"key":"B21","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12943-019-1109-9","article-title":"Functions of N6-Methyladenosine and Its Role in Cancer","volume":"18","author":"He","year":"2019","journal-title":"Mol Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","article-title":"The Potential Role of RNA N6-Methyladenosine in Cancer Progression","volume":"19","author":"Wang","year":"2020","journal-title":"Mol Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12943-019-1036-9","article-title":"METTL3 Promote Tumor Proliferation of Bladder Cancer by Accelerating pri-miR221\/222 Maturation in M6a-Dependent Manner","volume":"18","author":"Han","year":"2019","journal-title":"Mol Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nature24678","article-title":"Promoter-Bound METTL3 Maintains Myeloid Leukaemia by m(6)A-Dependent Translation Control","volume":"552","author":"Barbieri","year":"2017","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-20-0331","article-title":"The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells","volume":"11","author":"Dixit","year":"2021","journal-title":"Cancer Discovery"},{"key":"B26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12943-019-1053-8","article-title":"WTAP Facilitates Progression of Hepatocellular Carcinoma via M6a-HuR-Dependent Epigenetic Silencing of ETS1","volume":"18","author":"Chen","year":"2019","journal-title":"Mol Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41419-017-0129-x","article-title":"N6-Methyladenosine Links RNA Metabolism to Cancer Progression","volume":"9","author":"Dai","year":"2018","journal-title":"Cell Death Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-019-0461-z","article-title":"IGF2BP2 Regulates DANCR by Serving as an N6-Methyladenosine Reader","volume":"27","author":"Hu","year":"2020","journal-title":"Cell Death Differ"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103809","article-title":"Landscape of Transcription and Expression Regulated by DNA Methylation Related to Age of Donor and Cell Passage in Adipose-Derived Mesenchymal Stem Cells","volume":"12","author":"Lu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-Cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00695","article-title":"Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis","volume":"10","author":"Deng","year":"2019","journal-title":"Front Genet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.591937","article-title":"Integrative Analysis of Multi-Omics Identified the Prognostic Biomarkers in Acute Myelogenous Leukemia","volume":"10","author":"Zheng","year":"2020","journal-title":"Front Oncol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cmpb.2010.11.002","article-title":"SAS(\u00ae) Macro Implementation of a Multiple Comparison post hoc Test for a KRUSKAL-Wallis Analysis","volume":"102","author":"Elliott","year":"2011","journal-title":"Comput Methods Programs BioMed"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.05.048","article-title":"Perturbation of M6a Writers Reveals Two Distinct Classes of mRNA Methylation at Internal and 5\u2019 Sites","volume":"8","author":"Schwartz","year":"2014","journal-title":"Cell Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-cellbio-100616-060758","article-title":"Rethinking m(6)A Readers, Writers, and Erasers","volume":"33","author":"Meyer","year":"2017","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-018-0040-8","article-title":"Dynamic Transcriptomic m(6)A Decoration: Writers, Erasers, Readers and Functions in RNA Metabolism","volume":"28","author":"Yang","year":"2018","journal-title":"Cell Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2018.00089","article-title":"Link Between M6a Modification and Cancers","volume":"6","author":"Liu","year":"2018","journal-title":"Front Bioeng Biotechnol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103333","article-title":"M6A-Related Bioinformatics Analysis Reveals That HNRNPC Facilitates Progression of OSCC via EMT","volume":"12","author":"Huang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.594112","article-title":"Expression of M6a Regulators Correlated With Immune Microenvironment Predicts Therapeutic Efficacy and Prognosis in Gliomas","volume":"8","author":"Xu","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0312-8","article-title":"Tumor Mutational Load Predicts Survival After Immunotherapy Across Multiple Cancer Types","volume":"51","author":"Samstein","year":"2019","journal-title":"Nat Genet"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27172","article-title":"PD-1\/PD-L1 Immune Checkpoint: Potential Target for Cancer Therapy","volume":"234","author":"Dermani","year":"2019","journal-title":"J Cell Physiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/imcb.1003","article-title":"Immune Checkpoint Inhibitors in Cancer Therapy: A Focus on T-Regulatory Cells","volume":"96","author":"Sasidharan Nair","year":"2018","journal-title":"Immunol Cell Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz134","article-title":"Tumor Mutational Burden is Predictive of Response to Immune Checkpoint Inhibitors in MSI-High Metastatic Colorectal Cancer","volume":"30","author":"Schrock","year":"2019","journal-title":"Ann Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.789914\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T13:16:34Z","timestamp":1638278194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.789914\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,23]]},"references-count":43,"alternative-id":["10.3389\/fimmu.2021.789914"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.789914","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,23]]},"article-number":"789914"}}